Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson’s Disease

By Okuyama Satoshi   Semba Tomoki   Toyoda Nobuki   Epifano Francesco   Genovese Salvatore   Fiorito Serena   Taddeo Vito Alessandro   Sawamoto Atsushi   Nakajima Mitsunari   Furukawa Yoshiko  

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-10 ,pp. : 1716-1716

MDPI

Access to resources Recommend Favorite

Neuroprotective Properties of Mildronate, a Small Molecule, in a Rat Model of Parkinson’s Disease

By Klusa Vija Z.   Isajevs Sergejs   Svirina Darja   Pupure Jolanta   Beitnere Ulrika   Rumaks Juris   Svirskis Simons   Jansone Baiba   Dzirkale Zane   Muceniece Ruta   Kalvinsh Ivars   Vinters Harry V.  

International Journal of Molecular Sciences, Vol. 11, Iss. 11, 2010-11 ,pp. : 4465-4487

MDPI

Access to resources Recommend Favorite

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease

By Bae Woom-Yee   Choi Jae-Sun   Jeong Joo-Won  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 551-551

MDPI

Access to resources Recommend Favorite

Effects of Postnatal Enriched Environment in a Model of Parkinson’s Disease in Adult Rats

By Jungling Adel   Reglodi Dora   Karadi Zsofia Nozomi   Horvath Gabor   Farkas Jozsef   Gaszner Balazs   Tamas Andrea  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 406-406

MDPI

Access to resources Recommend Favorite

Protein Kinases and Parkinson’s Disease

By Mehdi Syed Jafar   Rosas-Hernandez Hector   Cuevas Elvis   Lantz Susan M.   Barger Steven W.   Sarkar Sumit   Paule Merle G.   Ali Syed F.   Imam Syed Z.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1585-1585

MDPI

Access to resources Recommend Favorite